title: Oligonucleotide therapies: the future of amyotrophic lateral sclerosis treatment?
authors.affiliation: Department of Physiology, Anatomy & Genetics, University of Oxford, South Parks Road, Oxford, OX1 3QX, UK.
authors.forename: Yoshitsugu
authors.initials: Y
authors.lastname: Aoki
authors.forename: Andrew Gl
authors.initials: AG
authors.lastname: Douglas
authors.forename: Matthew Ja
authors.initials: MJ
authors.lastname: Wood
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics / Q000628:therapy*; D000818:Animals; D000073885:C9orf72 Protein; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D009841:Oligonucleotides / Q000627:therapeutic use*; D011506:Proteins / Q000235:genetics; D013482:Superoxide Dismutase / Q000235:genetics; D000072105:Superoxide Dismutase-1
chemical_list: D000073885:C9orf72 Protein; C568651:C9orf72 protein, human; D009841:Oligonucleotides; D011506:Proteins; C000606290:SOD1 protein, human; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1
keywords: C9orf72; SOD1; amyotrophic lateral sclerosis; frontotemporal dementia; oligonucleotides ASO